Skip to content

Site Navigation

Exclusive Sponsored

PB Conference Learning Gallery

Search

Latest Stories

Start your day right!

Get the latest updates and insights delivered to your inbox

Enter your email

Exclusive Sponsored

PB Conference Learning Gallery

Advertise With Us Terms & Conditions Privacy Policy Cookie Policy Contact About Us Newsletter Subsciption Subscribe

Follow us

Home
astrazeneca

astrazeneca

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Longjam Dineshwori

Apr 11, 2025

AstraZeneca partners with CEPI to develop multi-specific influenza antibody

AstraZeneca secures £33M CEPI funding to develop multi-specific influenza antibody

Longjam Dineshwori

21 March

GSK plans to invest over £200 million to improve its UK sites

GSK plans to invest over £200 million to improve its UK sites

Longjam Dineshwori

17 January 2024

AstraZeneca UK amends ‘incorrect’ expiry dates of flu nasal spray vaccines

AstraZeneca UK amends ‘incorrect’ expiry dates of flu nasal spray vaccines

Longjam Dineshwori

30 November 2023

Recent

AstraZeneca to stop developing Crohn's disease drug

Pb Staff writer

Jun 01, 2023

AstraZeneca confident new COVID antibody protects against known variants

Pb Staff writer

Apr 18, 2023

AstraZeneca boosts heart, kidney business with $1.8 bln CinCor deal

Pb Staff writer

Jan 11, 2023

AstraZeneca boosts cancer portfolio with $320 mln Neogene deal

Pb Staff writer

Nov 29, 2022

UK's C4X Discovery signs $400m deal with AstraZeneca to develop treatment of respiratory diseases

Pb Staff writer

Nov 28, 2022

India gets ready to start administering Covid mix-and-match booster vaccines

pharmacy.biz Staff

Aug 11, 2022

AstraZeneca profits fall due to rising cost following takeover of US biotech firm Alexion

Pb Staff writer

Jul 29, 2022

AstraZeneca's Evusheld gets MHRA approval to treat Covid-19 patients

pharmacy.biz Staff

Mar 18, 2022

AstraZeneca inks pact with Scorpion Therapeutics to develop medicines against cancer proteins

Jan 13, 2022

UK marks first anniversary of Oxford-AstraZeneca vaccine

Jan 04, 2022

AstraZeneca to transfer global rights for Eklira and Duaklir to Covis Pharma

pharmacy.biz Staff

Nov 01, 2021

load more

Advertise With Us Terms & Conditions Privacy Policy Cookie Policy Contact About Us Newsletter Subsciption Subscribe

© Copyright 2025 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc